Developer docs
API playgroundTry for free, no card

Search company profiles

CareMed Specialty Pharmacy

Full company profile

uuid000bkch

Namestring
CareMed Specialty Pharmacy
Legal namestring
CareMed Specialty Pharmacy
Websiteurl
caremedsp.com
Company typeenum
Private
Founded yearint
2006
Descriptiontext

CareMed Specialty Pharmacy is a US-based specialty pharmacy headquartered in New Hyde Park, NY, founded in 1964 and operating with 101-250 employees. The company exclusively dispenses and manages therapies for patients with rare, ultra-rare, and complex diseases, serving four distinct constituencies: patients, healthcare providers, pharmaceutical manufacturers, and payers/health plans. Its core offering combines specialty medication dispensing with clinical care coordination, adherence support, patient education, and 24/7 patient access, supported by a digital surface area that includes a branded patient portal/app (mycaremed), online bill pay via PatientNotebook, e-statement enrollment, and a public provider-referral intake workflow. CareMed maintains HIPAA compliance and references pharmacy accreditations, though specific specialty accreditations are not named in available sources.

The business model is anchored on revenue from dispensing high-cost specialty medications, with cash inflow generated through payer reimbursements, payer network contracts, and pharmaceutical manufacturer limited-distribution arrangements. The company operates on a sales-led go-to-market motion, acquiring patients through healthcare-provider referrals, pharma manufacturer mandates that channel prescription volume directly to CareMed, and payer network selection. National Specialty Pharmacy Provider/Partner designations secured from Travere Therapeutics (VANRAFIA, April 2025), Cytokinetics (MYQORZO, January 2026), and GSK (Exdensur, January 2026) are the most visible commercial assets and validate the company's distribution reach across the United States. Geographic reach is national, serving U.S. patients exclusively.

Ownership is not explicitly disclosed in available source material. The company appears to operate as a privately held, independent entity with no public listing, no disclosed institutional investors, and no recorded funding rounds. A footer link to pharmerica.com/compliance/ suggests a possible — but unconfirmed — corporate relationship with PharMerica. There are no disclosed APIs, integrations, AI capabilities, patents, trademarks, or M&A activity, and the leadership team is not enumerated in the source data, representing a notable information gap for due diligence.

Short descriptiontext

CareMed Specialty Pharmacy is a US-based specialty pharmacy headquartered in New Hyde Park, NY, that dispenses and manages therapies for patients with rare, ultra-rare, and complex diseases via manufacturer partnerships, payer network contracts, and provider referrals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew Hyde Park, United States
HQ citystring
New Hyde Park
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmacy services, rare disease medications, patient care coordination, clinical care support, specialty medication dispensing
Industry2 codes
SECONDARYHLACAKAG
Specialty Pharmacy & Complex Therapy Management Platforms
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmacies and Drug Retailers45611
SIC code1 code
  • Retail-Drug Stores And Proprietary Stores5912
Product category
Specialty Pharmacy Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Specialty Pharmacy Dispensing and Care Services
TypeSubscription Recurring
Description

CareMed generates revenue by dispensing specialty medications to patients with rare, ultra-rare, and complex diseases, supported by clinical care coordination services. Revenue is derived from payer reimbursements, payer partnerships, and pharma manufacturer arrangements.

caremed.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

CareMed Specialty Pharmacy dispenses specialty medications for rare, ultra-rare, and complex diseases while providing personalized clinical support, patient care coordination, and adherence services. The company operates as a national specialty pharmacy provider designated by pharmaceutical manufacturers (GSK, Cytokinetics, Travere Therapeutics) and partners with healthcare providers, payers, and health plans to deliver coordinated treatment across the patient journey.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CareMed Specialty Pharmacy is a specialty pharmacy focused on rare, ultra-rare, and complex diseases. Their offering is a unified specialty pharmacy platform providing comprehensive services including: patient care with compassionate support and guidance throughout treatment journeys; provider support services for healthcare professionals; pharmaceutical commercialization partnerships for rare disease drug makers; and payer partnership programs. The platform manages specific specialty medications including Exdensur (depemokimab-ulaa), MYQORZO™ (aficamten), and VANRAFIA™ (atrasentan). Services are accessible through digital tools including a patient portal/app, online bill pay via PatientNotebook, and 24/7 customer support.

Product and service1 record
1Patient Care Services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-29
Description

CareMed was selected by GSK as a National Specialty Pharmacy Provider for Exdensur (depemokimab-ulaa), a specialty medication for a rare/ultra-rare condition. This designation channels prescriptions for this medication to CareMed and reflects a deep manufacturer-pharmacy partnership.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-12
Description

CareMed was selected by Cytokinetics as a National Specialty Pharmacy Provider for MYQORZO (aficamten). This partnership positions CareMed as the preferred specialty pharmacy channel for the medication, supporting patient access and medication management.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-03
Description

CareMed was selected by Travere Therapeutics as a National Specialty Pharmacy Partner for VANRAFIA (atrasentan). This partnership enables CareMed to dispense the medication and provide coordinated patient care services.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Soleo Health is a national specialty pharmacy and home infusion provider serving patients with complex and rare conditions, offering clinical care coordination and limited distribution drug dispensing. It is a comparable mid-sized specialty pharmacy that competes with CareMed for manufacturer partnerships and rare disease referrals.

2Biologics by McKesson
TypeBroad incumbent
Description

Biologics by McKesson is a specialty pharmacy focused on oncology and complex disease therapies, backed by McKesson's distribution scale. It is a comparable specialty dispensing and care-coordination platform competing for the same pharma manufacturer mandates as CareMed.

TypeBroad incumbent
Description

CVS Specialty is the specialty pharmacy arm of CVS Health, offering nationwide dispensing and clinical management for rare and complex conditions. As a large integrated payer-PBM-pharmacy, it competes with CareMed for both pharma launch partnerships and payer in-network status.

TypeDirect peer
Description

PANTHERx Rare is a specialty pharmacy exclusively focused on rare and orphan disease therapies, dispensing high-cost specialty medications and providing clinical care coordination. It directly competes with CareMed for the same pharma manufacturer mandates and rare-disease patient population.

TypeDirect peer
Description

Onco360 is a specialty pharmacy focused on oncology and rare disease therapies, providing care coordination and limited distribution drug dispensing. It competes with CareMed in the manufacturer-limited-distribution specialty space, though with a stronger oncology tilt.

TypeBroad incumbent
Description

Accredo is one of the largest US specialty pharmacies, operated by Evernorth/Express Scripts and dispensing across rare, oncology, and chronic specialty conditions. It is a dominant incumbent that competes with CareMed for pharma manufacturer limited distribution mandates and payer network placement.

TypeBroad incumbent
Description

Optum Specialty Pharmacy, built around the legacy Diplomat specialty pharmacy franchise, dispenses rare and specialty medications under UnitedHealth Group's Optum umbrella. It is a direct national competitor to CareMed for limited distribution drugs and payer relationships.

TypeEmerging player
Description

Trellis Rx operates embedded specialty pharmacy services within health systems, dispensing complex and specialty therapies in hospital and clinic settings. It represents an emerging distribution model that overlaps with CareMed's care-coordination value proposition, particularly around complex and rare disease therapies.

TypeBroad incumbent
Description

US Bioservices, part of Cencora (formerly AmerisourceBergen), is a specialty pharmacy dispensing rare, oncology, and chronic specialty therapies. It is a large incumbent competing for pharma mandates and payer network slots in the same space as CareMed.

TypeBroad incumbent
Description

Walgreens Specialty Pharmacy (including its AllianceRx Walgreens Prime business) provides dispensing and clinical services for specialty and rare disease therapies nationwide. It competes with CareMed for limited distribution drug networks and offers broader retail-pharmacy integration.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CareMed Specialty Pharmacy

Specialty Pharmacy Servicescaremedsp.com

CareMed Specialty Pharmacy is a US-based specialty pharmacy headquartered in New Hyde Park, NY, that dispenses and manages therapies for patients with rare, ultra-rare, and complex diseases via manufacturer partnerships, payer network contracts, and provider referrals.

What CareMed Specialty Pharmacy does

CareMed Specialty Pharmacy is a US-based specialty pharmacy headquartered in New Hyde Park, NY, founded in 1964 and operating with 101-250 employees. The company exclusively dispenses and manages therapies for patients with rare, ultra-rare, and complex diseases, serving four distinct constituencies: patients, healthcare providers, pharmaceutical manufacturers, and payers/health plans. Its core offering combines specialty medication dispensing with clinical care coordination, adherence support, patient education, and 24/7 patient access, supported by a digital surface area that includes a branded patient portal/app (mycaremed), online bill pay via PatientNotebook, e-statement enrollment, and a public provider-referral intake workflow. CareMed maintains HIPAA compliance and references pharmacy accreditations, though specific specialty accreditations are not named in available sources.

The business model is anchored on revenue from dispensing high-cost specialty medications, with cash inflow generated through payer reimbursements, payer network contracts, and pharmaceutical manufacturer limited-distribution arrangements. The company operates on a sales-led go-to-market motion, acquiring patients through healthcare-provider referrals, pharma manufacturer mandates that channel prescription volume directly to CareMed, and payer network selection. National Specialty Pharmacy Provider/Partner designations secured from Travere Therapeutics (VANRAFIA, April 2025), Cytokinetics (MYQORZO, January 2026), and GSK (Exdensur, January 2026) are the most visible commercial assets and validate the company's distribution reach across the United States. Geographic reach is national, serving U.S. patients exclusively.

Ownership is not explicitly disclosed in available source material. The company appears to operate as a privately held, independent entity with no public listing, no disclosed institutional investors, and no recorded funding rounds. A footer link to pharmerica.com/compliance/ suggests a possible — but unconfirmed — corporate relationship with PharMerica. There are no disclosed APIs, integrations, AI capabilities, patents, trademarks, or M&A activity, and the leadership team is not enumerated in the source data, representing a notable information gap for due diligence.

CareMed Specialty Pharmacy firmographics

Firmographics
Name
CareMed Specialty Pharmacy
Legal name
CareMed Specialty Pharmacy
Website
https://caremedsp.com
Company type
Private
Founded year
2006
Operating status
Operating
Headcount range
51–100 employees
Short description
CareMed Specialty Pharmacy is a US-based specialty pharmacy headquartered in New Hyde Park, NY, that dispenses and manages therapies for patients with rare, ultra-rare, and complex diseases via manufacturer partnerships, payer network contracts, and provider referrals.
Ownership category
akta.pro rank

Where CareMed Specialty Pharmacy is headquartered

Location

Headquarters

HQ city
New Hyde Park
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CareMed Specialty Pharmacy business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Specialty Pharmacy Dispensing and Care Services: CareMed generates revenue by dispensing specialty medications to patients with rare, ultra-rare, and complex diseases, supported by clinical care coordination services. Revenue is derived from payer reimbursements, payer partnerships, and pharma manufacturer arrangements.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

CareMed Specialty Pharmacy product offering

Product offering

Core offering

CareMed Specialty Pharmacy dispenses specialty medications for rare, ultra-rare, and complex diseases while providing personalized clinical support, patient care coordination, and adherence services. The company operates as a national specialty pharmacy provider designated by pharmaceutical manufacturers (GSK, Cytokinetics, Travere Therapeutics) and partners with healthcare providers, payers, and health plans to deliver coordinated treatment across the patient journey.

Product overview

CareMed Specialty Pharmacy is a specialty pharmacy focused on rare, ultra-rare, and complex diseases. Their offering is a unified specialty pharmacy platform providing comprehensive services including: patient care with compassionate support and guidance throughout treatment journeys; provider support services for healthcare professionals; pharmaceutical commercialization partnerships for rare disease drug makers; and payer partnership programs. The platform manages specific specialty medications including Exdensur (depemokimab-ulaa), MYQORZO™ (aficamten), and VANRAFIA™ (atrasentan). Services are accessible through digital tools including a patient portal/app, online bill pay via PatientNotebook, and 24/7 customer support.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patient Care Services

Companies that use CareMed Specialty Pharmacy

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

CareMed Specialty Pharmacy technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

CareMed Specialty Pharmacy partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • GSK (GlaxoSmithKline) — Exdensur (depemokimab-ulaa)coreStrategic or Co-development Partner · 29 January 2026CareMed was selected by GSK as a National Specialty Pharmacy Provider for Exdensur (depemokimab-ulaa), a specialty medication for a rare/ultra-rare condition. This designation channels prescriptions for this medication to CareMed and reflects a deep manufacturer-pharmacy partnership.
  • Cytokinetics — MYQORZO (aficamten)coreStrategic or Co-development Partner · 12 January 2026CareMed was selected by Cytokinetics as a National Specialty Pharmacy Provider for MYQORZO (aficamten). This partnership positions CareMed as the preferred specialty pharmacy channel for the medication, supporting patient access and medication management.
  • Travere Therapeutics — VANRAFIA (atrasentan)coreStrategic or Co-development Partner · 3 April 2025CareMed was selected by Travere Therapeutics as a National Specialty Pharmacy Partner for VANRAFIA (atrasentan). This partnership enables CareMed to dispense the medication and provide coordinated patient care services.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

CareMed Specialty Pharmacy competitors and assessment

Company assessment

Direct peers

  • Soleo Health: Soleo Health is a national specialty pharmacy and home infusion provider serving patients with complex and rare conditions, offering clinical care coordination and limited distribution drug dispensing. It is a comparable mid-sized specialty pharmacy that competes with CareMed for manufacturer partnerships and rare disease referrals.
  • PANTHERx Rare Pharmacy: PANTHERx Rare is a specialty pharmacy exclusively focused on rare and orphan disease therapies, dispensing high-cost specialty medications and providing clinical care coordination. It directly competes with CareMed for the same pharma manufacturer mandates and rare-disease patient population.
  • Onco360 Oncology Pharmacy Solutions: Onco360 is a specialty pharmacy focused on oncology and rare disease therapies, providing care coordination and limited distribution drug dispensing. It competes with CareMed in the manufacturer-limited-distribution specialty space, though with a stronger oncology tilt.

Broad incumbents

  • Biologics by McKesson: Biologics by McKesson is a specialty pharmacy focused on oncology and complex disease therapies, backed by McKesson's distribution scale. It is a comparable specialty dispensing and care-coordination platform competing for the same pharma manufacturer mandates as CareMed.
  • CVS Specialty: CVS Specialty is the specialty pharmacy arm of CVS Health, offering nationwide dispensing and clinical management for rare and complex conditions. As a large integrated payer-PBM-pharmacy, it competes with CareMed for both pharma launch partnerships and payer in-network status.
  • Accredo (Express Scripts): Accredo is one of the largest US specialty pharmacies, operated by Evernorth/Express Scripts and dispensing across rare, oncology, and chronic specialty conditions. It is a dominant incumbent that competes with CareMed for pharma manufacturer limited distribution mandates and payer network placement.
  • Optum Specialty Pharmacy (formerly Diplomat): Optum Specialty Pharmacy, built around the legacy Diplomat specialty pharmacy franchise, dispenses rare and specialty medications under UnitedHealth Group's Optum umbrella. It is a direct national competitor to CareMed for limited distribution drugs and payer relationships.
  • US Bioservices (AmerisourceBergen / Cencora): US Bioservices, part of Cencora (formerly AmerisourceBergen), is a specialty pharmacy dispensing rare, oncology, and chronic specialty therapies. It is a large incumbent competing for pharma mandates and payer network slots in the same space as CareMed.
  • Walgreens Specialty Pharmacy: Walgreens Specialty Pharmacy (including its AllianceRx Walgreens Prime business) provides dispensing and clinical services for specialty and rare disease therapies nationwide. It competes with CareMed for limited distribution drug networks and offers broader retail-pharmacy integration.

Emerging players

  • Trellis Rx (CPS Solutions): Trellis Rx operates embedded specialty pharmacy services within health systems, dispensing complex and specialty therapies in hospital and clinic settings. It represents an emerging distribution model that overlaps with CareMed's care-coordination value proposition, particularly around complex and rare disease therapies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key highlights5 records

Customer concentration

CareMed Specialty Pharmacy social profiles

Digital presence

CareMed Specialty Pharmacy compliance and trust

Trust signal

Compliance1 record

CareMed Specialty Pharmacy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CareMed Specialty Pharmacy leadership team

Management profile

Number of profiles

CareMed Specialty Pharmacy funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CareMed Specialty Pharmacy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CareMed Specialty Pharmacy

What does CareMed Specialty Pharmacy do?

CareMed Specialty Pharmacy dispenses specialty medications for rare, ultra-rare, and complex diseases while providing personalized clinical support, patient care coordination, and adherence services. The company operates as a national specialty pharmacy provider designated by pharmaceutical manufacturers (GSK, Cytokinetics, Travere Therapeutics) and partners with healthcare providers, payers, and health plans to deliver coordinated treatment across the patient journey.

Is CareMed Specialty Pharmacy a public or private company?

CareMed Specialty Pharmacy is a private company. It is classified as unknown and is currently operating.

When was CareMed Specialty Pharmacy founded?

CareMed Specialty Pharmacy was founded in 2006. It employs 51 to 100 people.

Where is CareMed Specialty Pharmacy based?

CareMed Specialty Pharmacy is headquartered in New Hyde Park, United States, in the North America region.

How does CareMed Specialty Pharmacy make money?

One revenue line is on record: specialty Pharmacy Dispensing and Care Services.

Who are CareMed Specialty Pharmacy's main competitors?

Direct peers on record are Soleo Health, PANTHERx Rare Pharmacy and Onco360 Oncology Pharmacy Solutions. Broad incumbents are Biologics by McKesson, CVS Specialty, Accredo (Express Scripts), Optum Specialty Pharmacy (formerly Diplomat), US Bioservices (AmerisourceBergen / Cencora) and Walgreens Specialty Pharmacy. Trellis Rx (CPS Solutions) is listed as an emerging player.

Does CareMed Specialty Pharmacy have an API?

No public API is recorded for CareMed Specialty Pharmacy.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceCareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease PortfolioCareMed was selected as a pharmacy partner by BioCryst for Orladeyo (berotralstat), a plasma kallikrein inhibitor for hereditary angioedema prophylaxis in adults and children 2 years and older. The addition reinforces CareMed's commitment to rare disease care and positions it as a trusted partner for patients, providers, and manufacturers.FinancialContent Business PageCareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease PortfolioCareMed was selected as a pharmacy partner by BioCryst for Orladeyo (berotralstat), a plasma kallikrein inhibitor for hereditary angioedema prophylaxis in adults and children 2 years and older. The addition reinforces CareMed's commitment to rare disease care and positions it as a trusted partner for patients, providers, and manufacturers.GlobeNewswireCareMed Has Been Selected as a National Specialty Pharmacy Provider for Exdensur (depemokimab-ulaa)CareMed was selected as a pharmacy partner by GSK for Exdensur, an ultra-long-acting biologic for severe eosinophilic asthma in patients 12 and older. The drug is dosed every six months, with FDA approval based on two trials and common adverse reactions including upper respiratory infections.GlobeNewswireCareMed Has Been Selected as a National Specialty Pharmacy Provider for MYQORZO™ (aficamten)CareMed was selected as a pharmacy partner for Cytokinetics' MYQORZO, an inhibitor for obstructive hypertrophic cardiomyopathy. The drug's approval is based on the SEQUOIA-HCM trial, which showed a 1.8 mL/kg/min increase in peak oxygen uptake versus placebo. CareMed will support patients and caregivers throughout treatment.GlobeNewswireCareMed Has Been Selected as a National Specialty Pharmacy Partner for VANRAFIA™ (atrasentan)CareMed has been selected as a national specialty pharmacy partner for Vanrafia (atrasentan), a once-daily oral therapy for primary IgA nephropathy. The FDA granted accelerated approval based on the Phase III ALIGN study, which showed a 38.1% proteinuria reduction versus placebo at 36 weeks. The drug is added to supportive care including RAS and SGLT2 inhibitors.GlobeNewswireBrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®CareMed, a BrightSpring company, was selected by Eisai as the national specialty pharmacy provider for Leqembi, a treatment for Alzheimer's disease. Leqembi's FDA approval is based on a Phase III trial of 1,795 patients showing slowed cognitive decline over 18 months. CareMed's CEO expressed confidence in the medication's impact on patient quality of life.YahooBrightSpring Health Services Announces CareMed Was Selected as a National Specialty Pharmacy Partner for Leqembi®CareMed, a BrightSpring company, was selected by Eisai as the national specialty pharmacy provider for Leqembi, a treatment for Alzheimer's disease. Leqembi's FDA approval is based on a Phase III trial of 1,795 patients showing slowed cognitive decline over 18 months. The partnership aims to expand access to the medication.GlobeNewswireCareMed Has Been Selected as a National Specialty Pharmacy Partner for Lecanemab-irmb (Leqembi®)CareMed was selected by Eisai to be in the pharmacy network for Leqembi, a monoclonal antibody for Alzheimer's disease. The FDA approval is based on a Phase III trial of 1,795 patients showing a 0.45-point greater improvement in CDR-SB scores with Leqembi versus placebo. The company plans to expand its portfolio with this treatment option.PR NewswireOnco360 and CareMed Specialty Pharmacy Patients Notified of Data Security IncidentOnco360 and CareMed Specialty Pharmacy identified suspicious activity in employee email accounts on November 14, 2017, and an investigation determined an unauthorized user had accessed three employees' email accounts. The forensic review completed on January 8, 2018 revealed that compromised emails may have contained patient demographic information, medication and clinical information, health insurance information, Social Security numbers, and in a small number of cases, financial account information. The companies, which are subsidiaries of PharMerica, have taken remediation steps including password changes, employee training, enhanced email security measures, and law enforcement reporting, while offering affected individuals free credit monitoring and identity protection services.